Loading…

Serum and Bronchoalveolar Lavage Fluid Galactomannan Assays in Patients with Pulmonary Aspergilloma

The sensitivities of the serum and bronchoalveolar lavage galactomannan (GM) assays in 48 patients with pulmonary aspergilloma were 38% (13 of 34; 95% confidence interval [CI], 22%-56%) and 92% (33 of 36; 95% CI, 78%-98%), respectively. The positivity of serum GM assays was significantly higher in p...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2011-04, Vol.52 (7), p.e149-e152
Main Authors: Park, Seong Yeon, Lee, Sang-Oh, Choi, Sang-Ho, Jeong, Jin-Yong, Sung, Heungsup, Kim, Mi-Na, Choi, Chang-Min, Hong, Sang-Bum, Oh, Yeon-Mok, Shim, Tae-Sun, Lim, Chae-Man, Koh, Younsuck, Kim, Dong Soon, Kim, Yang Soo, Woo, Jun Hee, Kim, Sung-Han
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The sensitivities of the serum and bronchoalveolar lavage galactomannan (GM) assays in 48 patients with pulmonary aspergilloma were 38% (13 of 34; 95% confidence interval [CI], 22%-56%) and 92% (33 of 36; 95% CI, 78%-98%), respectively. The positivity of serum GM assays was significantly higher in patients with hemoptysis than in those without hemoptysis (52% vs 9%; P 5 .02). The sensitivities of the serum and bronchoalveolar lavage galactomannan (GM) assays in 48 patients with pulmonary aspergilloma were 38% (13 of 34; 95% confidence interval [CI], 22%-56%) and 92% (33 of 36; 95% CI, 78%-98%), respectively. The positivity of serum GM assays was significantly higher in patients with hemoptysis than in those without hemoptysis (52% vs 9%; P = .02).
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/cir027